speb/financial-data huggingface dataset:
HIVE income_statement (annual, 2026-03-31) — Reconciled Depreciation: 170425000.00
HIVE income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 52702000.00
HIVE cash_flow (annual, 2026-03-31) — Repayment Of Debt: -38074000.00
HIVE cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -445000.00
HIVE balance_sheet (annual, 2026-03-31) — Retained Earnings: -422310000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -422310000.00
HIVE income_statement (annual, 2026-03-31) — Salaries And Wages: 34161000.00
HIVE income_statement (quarterly, 2026-03-31) — Salaries And Wages: 9491000.00
HIVE cash_flow (annual, 2026-03-31) — Sale Of Investment: 0.00
HIVE cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 0.00
HIVE cash_flow (annual, 2026-03-31) — Sale Of PPE: 1608000.00
HIVE cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 0.00
HIVE income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 2571000.00
HIVE income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 804000.00
HIVE income_statement (annual, 2026-03-31) — Selling General And Administration: 56849000.00
HIVE income_statement (quarterly, 2026-03-31) — Selling General And Administration: 16632000.00
HIVE balance_sheet (annual, 2026-03-31) — Share Issued: 259348106.00
HIVE balance_sheet (quarterly, 2026-03-31) — Share Issued: 259348106.00
HIVE income_statement (annual, 2026-03-31) — Special Income Charges: 10286000.00
HIVE income_statement (quarterly, 2026-03-31) — Special Income Charges: 10742000.00
HIVE cash_flow (annual, 2026-03-31) — Stock Based Compensation: 25457000.00
HIVE cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 7237000.00
HIVE balance_sheet (annual, 2026-03-31) — Stockholders Equity: 529359000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 529359000.00
HIVE balance_sheet (annual, 2026-03-31) — Tangible Book Value: 529359000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 529359000.00
HIVE income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -11535200.00
HIVE income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -9355600.00
HIVE income_statement (annual, 2026-03-31) — Tax Provision: 3867000.00
HIVE income_statement (quarterly, 2026-03-31) — Tax Provision: 1703000.00
HIVE income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.40
HIVE income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
HIVE balance_sheet (annual, 2026-03-31) — Total Assets: 639146000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Total Assets: 639146000.00
HIVE balance_sheet (annual, 2026-03-31) — Total Capitalization: 553204000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 553204000.00
HIVE balance_sheet (annual, 2026-03-31) — Total Debt: 71066000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Total Debt: 71066000.00
HIVE balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 529359000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 529359000.00
HIVE income_statement (annual, 2026-03-31) — Total Expenses: 414253000.00
HIVE income_statement (quarterly, 2026-03-31) — Total Expenses: 123620000.00
HIVE balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 109787000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 109787000.00
HIVE balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 579299000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 579299000.00
HIVE balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 55352000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 55352000.00
HIVE balance_sheet (annual, 2026-03-31) — Total Tax Payable: 10968000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 10968000.00
HIVE income_statement (annual, 2026-03-31) — Total Unusual Items: -28838000.00
HIVE income_statement (quarterly, 2026-03-31) — Total Unusual Items: -23389000.00
HIVE income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -28838000.00
HIVE income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -23389000.00
HIVE balance_sheet (annual, 2026-03-31) — Working Capital: 5413000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Working Capital: 5413000.00
HIVE income_statement (annual, 2026-03-31) — Write Off: 1816000.00
HIVE income_statement (quarterly, 2026-03-31) — Write Off: 0.00
HIVE.V income_statement (annual, 2022-03-31) — +Operating Expense: 17630328.00
HIVE.V income_statement (annual, 2022-03-31) — +Total Revenue: 211184029.00
HIVE.V balance_sheet (annual, 2022-03-31) — Accounts Payable: 7765802.00
HIVE.V balance_sheet (annual, 2022-03-31) — Accounts Receivable: 6758017.00
HIVE.V balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -152630597.00
HIVE.V cash_flow (annual, 2022-03-31) — Asset Impairment Charge: 13330029.00
HIVE.V income_statement (annual, 2022-03-31) — Basic Average Shares: 77715890.00
HIVE.V income_statement (annual, 2022-03-31) — Basic EPS: 1.02
HIVE.V cash_flow (annual, 2022-03-31) — Beginning Cash Position: 40290513.00
HIVE.V balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 17537720.00
HIVE.V cash_flow (annual, 2022-03-31) — Capital Expenditure: -212842436.00
HIVE.V balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 12649194.00
HIVE.V balance_sheet (annual, 2022-03-31) — Capital Stock: 413660484.00
HIVE.V balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 5318922.00
HIVE.V balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 22319664.00
HIVE.V balance_sheet (annual, 2022-03-31) — Cash Financial: 5318922.00
HIVE.V cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Financing Activities: 110774892.00
HIVE.V cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Investing Activities: -211987500.00
HIVE.V cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Operating Activities: 66279290.00
HIVE.V cash_flow (annual, 2022-03-31) — Change In Account Payable: 5137168.00
HIVE.V cash_flow (annual, 2022-03-31) — Change In Income Tax Payable: 53718.00
HIVE.V cash_flow (annual, 2022-03-31) — Change In Other Current Assets: 117488692.00
HIVE.V cash_flow (annual, 2022-03-31) — Change In Payable: 5190886.00
HIVE.V cash_flow (annual, 2022-03-31) — Change In Payables And Accrued Expense: 5190886.00
HIVE.V cash_flow (annual, 2022-03-31) — Change In Receivables: 60014.00
HIVE.V cash_flow (annual, 2022-03-31) — Change In Tax Payable: 53718.00
HIVE.V cash_flow (annual, 2022-03-31) — Change In Working Capital: 122739592.00
HIVE.V cash_flow (annual, 2022-03-31) — Changes In Cash: -34933318.00
HIVE.V balance_sheet (annual, 2022-03-31) — Common Stock: 413660484.00
HIVE.V balance_sheet (annual, 2022-03-31) — Common Stock Equity: 389052565.00
HIVE.V cash_flow (annual, 2022-03-31) — Common Stock Issuance: 33907451.00
HIVE.V income_statement (annual, 2022-03-31) — Cost Of Revenue: 114272932.00
HIVE.V balance_sheet (annual, 2022-03-31) — Current Accrued Expenses: 3965194.00
HIVE.V balance_sheet (annual, 2022-03-31) — Current Assets: 199078093.00
HIVE.V balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 2164658.00
HIVE.V balance_sheet (annual, 2022-03-31) — Current Debt: 10599346.00
HIVE.V balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 12764004.00
HIVE.V balance_sheet (annual, 2022-03-31) — Current Liabilities: 26154632.00
HIVE.V cash_flow (annual, 2022-03-31) — Deferred Income Tax: 2416000.00
HIVE.V cash_flow (annual, 2022-03-31) — Deferred Tax: 2416000.00
HIVE.V cash_flow (annual, 2022-03-31) — Depreciation Amortization Depletion: 67021722.00
HIVE.V cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 67021722.00
HIVE.V balance_sheet (annual, 2022-03-31) — Derivative Product Liabilities: 4986354.00
HIVE.V income_statement (annual, 2022-03-31) — Diluted Average Shares: 84808329.00
HIVE.V income_statement (annual, 2022-03-31) — Diluted EPS: 0.94
HIVE.V income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 79622129.00
HIVE.V income_statement (annual, 2022-03-31) — EBIT: 85908241.00
HIVE.V income_statement (annual, 2022-03-31) — EBITDA: 152929963.00
HIVE.V cash_flow (annual, 2022-03-31) — Effect Of Exchange Rate Changes: -38273.00
HIVE.V cash_flow (annual, 2022-03-31) — End Cash Position: 5318922.00
HIVE.V cash_flow (annual, 2022-03-31) — Financing Cash Flow: 110774892.00
HIVE.V balance_sheet (annual, 2022-03-31) — Finished Goods: 170000412.00
HIVE.V cash_flow (annual, 2022-03-31) — Free Cash Flow: -146563146.00
HIVE.V cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -220359870.00
HIVE.V cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of Business: -3171275.00
HIVE.V cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: -2206531.00
HIVE.V income_statement (annual, 2022-03-31) — Gain On Sale Of Business: 3171275.00
HIVE.V income_statement (annual, 2022-03-31) — Gain On Sale Of Ppe: 2206531.00
HIVE.V income_statement (annual, 2022-03-31) — Gain On Sale Of Security: 14579695.00
HIVE.V balance_sheet (annual, 2022-03-31) — Gains Losses Not Affecting Retained Earnings: 35635637.00
HIVE.V income_statement (annual, 2022-03-31) — General And Administrative Expense: 17113352.00
HIVE.V balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 335594.00
HIVE.V balance_sheet (annual, 2022-03-31) — Gross PPE: 342761223.00
HIVE.V income_statement (annual, 2022-03-31) — Gross Profit: 96911097.00
HIVE.V income_statement (annual, 2022-03-31) — Impairment Of Capital Assets: 13330029.00
HIVE.V cash_flow (annual, 2022-03-31) — Income Tax Paid Supplemental Data: 0.00
HIVE.V balance_sheet (annual, 2022-03-31) — Income Tax Payable: 1013803.00
HIVE.V income_statement (annual, 2022-03-31) — Interest Expense: 3870112.00
HIVE.V income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 3870112.00
HIVE.V cash_flow (annual, 2022-03-31) — Interest Paid Supplemental Data: 286047.00
HIVE.V balance_sheet (annual, 2022-03-31) — Inventory: 170000412.00
HIVE.V balance_sheet (annual, 2022-03-31) — Invested Capital: 424705509.00
HIVE.V cash_flow (annual, 2022-03-31) — Investing Cash Flow: -211987500.00
HIVE.V cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 33907451.00
HIVE.V cash_flow (annual, 2022-03-31) — Issuance Of Debt: 0.00
HIVE.V balance_sheet (annual, 2022-03-31) — Land And Improvements: 662910.00
HIVE.V balance_sheet (annual, 2022-03-31) — Line Of Credit: 9375244.00
HIVE.V balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 10484536.00
HIVE.V balance_sheet (annual, 2022-03-31) — Long Term Debt: 25053598.00
HIVE.V balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 35538134.00
HIVE.V cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 0.00
HIVE.V cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -6453712.00
HIVE.V balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 306802142.00
HIVE.V cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: -237254.00
HIVE.V cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 33907451.00
HIVE.V balance_sheet (annual, 2022-03-31) — Net Debt: 30334022.00
HIVE.V cash_flow (annual, 2022-03-31) — Net Foreign Currency Exchange Gain Loss: -3297820.00
HIVE.V income_statement (annual, 2022-03-31) — Net Income: 79622129.00
HIVE.V income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 79622129.00
HIVE.V income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 79622129.00
HIVE.V income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 79622129.00
HIVE.V income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 79622129.00
HIVE.V cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 79622129.00
HIVE.V income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 79622129.00
HIVE.V income_statement (annual, 2022-03-31) — Net Interest Income: -3870112.00
HIVE.V cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: -1886666.00
HIVE.V cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: -9176251.00
HIVE.V cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: -9176251.00
HIVE.V income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -3870112.00
HIVE.V balance_sheet (annual, 2022-03-31) — Net PPE: 190130626.00
HIVE.V cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -209863580.00
HIVE.V balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 388716971.00
HIVE.V balance_sheet (annual, 2022-03-31) — Non Current Accounts Receivable: 3036274.00
HIVE.V balance_sheet (annual, 2022-03-31) — Non Current Deferred Liabilities: 1529000.00
HIVE.V balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 1529000.00
HIVE.V balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 59693744.00
HIVE.V income_statement (annual, 2022-03-31) — Normalized EBITDA: 146302491.00
HIVE.V income_statement (annual, 2022-03-31) — Normalized Income: 73189834.20
HIVE.V cash_flow (annual, 2022-03-31) — Operating Cash Flow: 66279290.00
HIVE.V cash_flow (annual, 2022-03-31) — Operating Gains Losses: -229035496.00
HIVE.V income_statement (annual, 2022-03-31) — Operating Income: 79280769.00
HIVE.V income_statement (annual, 2022-03-31) — Operating Revenue: 211184029.00
HIVE.V balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 82241988.00
HIVE.V balance_sheet (annual, 2022-03-31) — Other Current Borrowings: 1224102.00
HIVE.V balance_sheet (annual, 2022-03-31) — Other Equity Adjustments: 35635637.00
HIVE.V income_statement (annual, 2022-03-31) — Other Gand A: 9100144.00
HIVE.V income_statement (annual, 2022-03-31) — Other Income Expense: 6627472.00
HIVE.V cash_flow (annual, 2022-03-31) — Other Non Cash Items: 2594242.00
HIVE.V income_statement (annual, 2022-03-31) — Other Operating Expenses: -75861.00
HIVE.V balance_sheet (annual, 2022-03-31) — Other Payable: 645829.00
HIVE.V balance_sheet (annual, 2022-03-31) — Other Properties: 324560593.00
HIVE.V balance_sheet (annual, 2022-03-31) — Other Short Term Investments: 17000742.00
HIVE.V balance_sheet (annual, 2022-03-31) — Payables: 9425434.00
HIVE.V balance_sheet (annual, 2022-03-31) — Payables And Accrued Expenses: 13390628.00
HIVE.V income_statement (annual, 2022-03-31) — Pretax Income: 82038129.00
HIVE.V cash_flow (annual, 2022-03-31) — Proceeds From Stock Option Exercised: 86043692.00
HIVE.V balance_sheet (annual, 2022-03-31) — Properties: 0.00
HIVE.V cash_flow (annual, 2022-03-31) — Purchase Of Business: -237254.00
HIVE.V cash_flow (annual, 2022-03-31) — Purchase Of Investment: -1886666.00
HIVE.V cash_flow (annual, 2022-03-31) — Purchase Of PPE: -212842436.00
HIVE.V balance_sheet (annual, 2022-03-31) — Receivables: 6758017.00
HIVE.V income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 114272932.00
HIVE.V income_statement (annual, 2022-03-31) — Reconciled Depreciation: 67021722.00
HIVE.V cash_flow (annual, 2022-03-31) — Repayment Of Debt: -6453712.00
HIVE.V balance_sheet (annual, 2022-03-31) — Retained Earnings: -60243556.00
HIVE.V income_statement (annual, 2022-03-31) — Salaries And Wages: 8013208.00
HIVE.V cash_flow (annual, 2022-03-31) — Sale Of PPE: 2978856.00
HIVE.V income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 592837.00
HIVE.V income_statement (annual, 2022-03-31) — Selling General And Administration: 17706189.00
HIVE.V balance_sheet (annual, 2022-03-31) — Share Issued: 82241988.00
HIVE.V income_statement (annual, 2022-03-31) — Special Income Charges: -7952223.00
HIVE.V cash_flow (annual, 2022-03-31) — Stock Based Compensation: 6753250.00
HIVE.V balance_sheet (annual, 2022-03-31) — Stockholders Equity: 389052565.00
HIVE.V balance_sheet (annual, 2022-03-31) — Tangible Book Value: 388716971.00
HIVE.V income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 195177.20
HIVE.V income_statement (annual, 2022-03-31) — Tax Provision: 2416000.00
HIVE.V income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.03
HIVE.V balance_sheet (annual, 2022-03-31) — Total Assets: 452274331.00
HIVE.V balance_sheet (annual, 2022-03-31) — Total Capitalization: 414106163.00
HIVE.V balance_sheet (annual, 2022-03-31) — Total Debt: 48302138.00
HIVE.V balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 389052565.00
HIVE.V income_statement (annual, 2022-03-31) — Total Expenses: 131903260.00
HIVE.V balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 63221766.00
HIVE.V balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 253196238.00
HIVE.V balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 37067134.00
HIVE.V balance_sheet (annual, 2022-03-31) — Total Tax Payable: 1013803.00
HIVE.V income_statement (annual, 2022-03-31) — Total Unusual Items: 6627472.00
HIVE.V income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: 6627472.00
HIVE.V cash_flow (annual, 2022-03-31) — Unrealized Gain Loss On Investment Securities: 837822.00
HIVE.V balance_sheet (annual, 2022-03-31) — Working Capital: 172923461.00
HIVE.V income_statement (annual, 2022-03-31) — Write Off: 0.00
HIVE.V income_statement (annual, 2023-03-31) — +Operating Expense: 21621000.00
HIVE.V income_statement (annual, 2023-03-31) — +Total Revenue: 106318000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Accounts Payable: 6859000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Accounts Receivable: 9354000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -175479000.00
HIVE.V cash_flow (annual, 2023-03-31) — Asset Impairment Charge: 97741000.00
HIVE.V income_statement (annual, 2023-03-31) — Basic Average Shares: 82871284.00
HIVE.V income_statement (annual, 2023-03-31) — Basic EPS: -2.85
HIVE.V cash_flow (annual, 2023-03-31) — Beginning Cash Position: 5319000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 26528000.00
HIVE.V cash_flow (annual, 2023-03-31) — Capital Expenditure: -42829000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 10468000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Capital Stock: 419213000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 4373000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 7239000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Cash Financial: 4373000.00
HIVE.V cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Financing Activities: -4639000.00
HIVE.V cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Investing Activities: -40887000.00
HIVE.V cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Operating Activities: 44782000.00
HIVE.V cash_flow (annual, 2023-03-31) — Change In Account Payable: -3802895.00
HIVE.V cash_flow (annual, 2023-03-31) — Change In Income Tax Payable: 0.00
HIVE.V cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 195079000.00
HIVE.V cash_flow (annual, 2023-03-31) — Change In Payable: -3802895.00
HIVE.V cash_flow (annual, 2023-03-31) — Change In Payables And Accrued Expense: -3802000.00
HIVE.V cash_flow (annual, 2023-03-31) — Change In Receivables: -5374000.00
HIVE.V cash_flow (annual, 2023-03-31) — Change In Tax Payable: 0.00
HIVE.V cash_flow (annual, 2023-03-31) — Change In Working Capital: 185903000.00
HIVE.V cash_flow (annual, 2023-03-31) — Changes In Cash: -744000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Common Stock: 419213000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Common Stock Equity: 148815000.00
HIVE.V cash_flow (annual, 2023-03-31) — Common Stock Issuance: 3802000.00
HIVE.V income_statement (annual, 2023-03-31) — Cost Of Revenue: 137193000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Current Accrued Expenses: 2362000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Current Assets: 82492000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 2330000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Current Debt: 9538000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 11868000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Current Liabilities: 23068000.00
HIVE.V cash_flow (annual, 2023-03-31) — Deferred Income Tax: 289000.00
HIVE.V cash_flow (annual, 2023-03-31) — Deferred Tax: 289000.00
HIVE.V cash_flow (annual, 2023-03-31) — Depreciation: 81730000.00
HIVE.V cash_flow (annual, 2023-03-31) — Depreciation Amortization Depletion: 81730000.00
HIVE.V cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 81730000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Derivative Product Liabilities: 481998.00
HIVE.V income_statement (annual, 2023-03-31) — Diluted Average Shares: 82871284.00
HIVE.V income_statement (annual, 2023-03-31) — Diluted EPS: -2.85
HIVE.V income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -236423000.00
HIVE.V income_statement (annual, 2023-03-31) — EBIT: -232172000.00
HIVE.V income_statement (annual, 2023-03-31) — EBITDA: -150442000.00
HIVE.V cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: -202000.00
HIVE.V cash_flow (annual, 2023-03-31) — End Cash Position: 4373000.00
HIVE.V cash_flow (annual, 2023-03-31) — Financing Cash Flow: -4639000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Finished Goods: 65899000.00
HIVE.V cash_flow (annual, 2023-03-31) — Free Cash Flow: 1953000.00
HIVE.V cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -110593000.00
HIVE.V cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of Business: 0.00
HIVE.V cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 1395000.00
HIVE.V income_statement (annual, 2023-03-31) — Gain On Sale Of Business: 0.00
HIVE.V income_statement (annual, 2023-03-31) — Gain On Sale Of Ppe: -18331000.00
HIVE.V income_statement (annual, 2023-03-31) — Gain On Sale Of Security: -7683000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Gains Losses Not Affecting Retained Earnings: 26268000.00
HIVE.V income_statement (annual, 2023-03-31) — General And Administrative Expense: 20602000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 67000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Gross PPE: 273680000.00
HIVE.V income_statement (annual, 2023-03-31) — Gross Profit: -30875000.00
HIVE.V income_statement (annual, 2023-03-31) — Impairment Of Capital Assets: 70410000.00
HIVE.V cash_flow (annual, 2023-03-31) — Income Tax Paid Supplemental Data: 0.00
HIVE.V balance_sheet (annual, 2023-03-31) — Income Tax Payable: 1846000.00
HIVE.V income_statement (annual, 2023-03-31) — Interest Expense: 3962000.00
HIVE.V income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 3962000.00
HIVE.V cash_flow (annual, 2023-03-31) — Interest Paid Supplemental Data: 1977000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Inventory: 65899000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Invested Capital: 174243000.00
HIVE.V cash_flow (annual, 2023-03-31) — Investing Cash Flow: -40887000.00
HIVE.V cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 3802000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Land And Improvements: 663000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Line Of Credit: 7139000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 8138000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Long Term Debt: 15890000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 24028000.00
HIVE.V cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -5767000.00
HIVE.V cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 0.00
HIVE.V cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 3802000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Net Debt: 21055000.00
HIVE.V cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 136000.00
HIVE.V income_statement (annual, 2023-03-31) — Net Income: -236423000.00
HIVE.V income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -236423000.00
HIVE.V income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -236423000.00
HIVE.V income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -236423000.00
HIVE.V income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -236423000.00
HIVE.V cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -236423000.00
HIVE.V income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -236423000.00
HIVE.V income_statement (annual, 2023-03-31) — Net Interest Income: -3962000.00
HIVE.V cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 0.00
HIVE.V cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -8441000.00
HIVE.V cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -8441000.00
HIVE.V income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -3962000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Net PPE: 98201000.00
HIVE.V cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -40887000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 148748000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Non Current Accounts Receivable: 5815000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Non Current Deferred Liabilities: 206000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 206000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 9542000.00
HIVE.V income_statement (annual, 2023-03-31) — Normalized EBITDA: -26687000.00
HIVE.V income_statement (annual, 2023-03-31) — Normalized Income: -138656550.00
HIVE.V cash_flow (annual, 2023-03-31) — Operating Cash Flow: 44782000.00
HIVE.V cash_flow (annual, 2023-03-31) — Operating Gains Losses: -109062000.00
HIVE.V income_statement (annual, 2023-03-31) — Operating Income: -52496000.00
HIVE.V income_statement (annual, 2023-03-31) — Operating Revenue: 106318000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 82241988.00
HIVE.V balance_sheet (annual, 2023-03-31) — Other Current Borrowings: 2399000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Other Equity Adjustments: 26268000.00
HIVE.V income_statement (annual, 2023-03-31) — Other Gand A: 9233000.00
HIVE.V income_statement (annual, 2023-03-31) — Other Income Expense: -179676000.00
HIVE.V cash_flow (annual, 2023-03-31) — Other Non Cash Items: 2794000.00
HIVE.V income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: -55921000.00
HIVE.V income_statement (annual, 2023-03-31) — Other Operating Expenses: 72715233.00
HIVE.V balance_sheet (annual, 2023-03-31) — Other Payable: 133000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Other Properties: 246489000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 2866000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Payables: 8838000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Payables And Accrued Expenses: 11200000.00
HIVE.V income_statement (annual, 2023-03-31) — Pretax Income: -236134000.00
HIVE.V cash_flow (annual, 2023-03-31) — Proceeds From Stock Option Exercised: 0.00
HIVE.V balance_sheet (annual, 2023-03-31) — Properties: 0.00
HIVE.V income_statement (annual, 2023-03-31) — Provision For Doubtful Accounts: 0.00
HIVE.V cash_flow (annual, 2023-03-31) — Purchase Of Business: 0.00
HIVE.V cash_flow (annual, 2023-03-31) — Purchase Of Investment: 0.00
HIVE.V cash_flow (annual, 2023-03-31) — Purchase Of PPE: -42829000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Receivables: 9354000.00
HIVE.V income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 137193000.00
HIVE.V income_statement (annual, 2023-03-31) — Reconciled Depreciation: 81730000.00
HIVE.V cash_flow (annual, 2023-03-31) — Repayment Of Debt: -5767000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Retained Earnings: -296666000.00
HIVE.V income_statement (annual, 2023-03-31) — Salaries And Wages: 11369000.00
HIVE.V cash_flow (annual, 2023-03-31) — Sale Of PPE: 1942000.00
HIVE.V income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 1019000.00
HIVE.V income_statement (annual, 2023-03-31) — Selling General And Administration: 21621000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Share Issued: 82241988.00
HIVE.V income_statement (annual, 2023-03-31) — Special Income Charges: -116072000.00
HIVE.V cash_flow (annual, 2023-03-31) — Stock Based Compensation: 8378000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Stockholders Equity: 148815000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Tangible Book Value: 148748000.00
HIVE.V income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -25988550.00
HIVE.V income_statement (annual, 2023-03-31) — Tax Provision: 289000.00
HIVE.V income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.21
HIVE.V balance_sheet (annual, 2023-03-31) — Total Assets: 196117000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Total Capitalization: 164705000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Total Debt: 35896000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 148815000.00
HIVE.V income_statement (annual, 2023-03-31) — Total Expenses: 158814000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 47302000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 113625000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 24234000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Total Tax Payable: 1846000.00
HIVE.V income_statement (annual, 2023-03-31) — Total Unusual Items: -123755000.00
HIVE.V income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -123755000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Treasury Shares Number: 0.00
HIVE.V cash_flow (annual, 2023-03-31) — Unrealized Gain Loss On Investment Securities: 13432000.00
HIVE.V balance_sheet (annual, 2023-03-31) — Working Capital: 59424000.00
HIVE.V income_statement (annual, 2023-03-31) — Write Off: 27331000.00
HIVE.V income_statement (annual, 2024-03-31) — +Operating Expense: 27230000.00
HIVE.V income_statement (annual, 2024-03-31) — +Total Revenue: 114465000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Accounts Payable: 7466000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Accounts Receivable: 6929000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -231713000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 523949000.00
HIVE.V cash_flow (annual, 2024-03-31) — Asset Impairment Charge: 0.00
HIVE.V income_statement (annual, 2024-03-31) — Basic Average Shares: 90005128.00
HIVE.V income_statement (annual, 2024-03-31) — Basic EPS: 0.29
HIVE.V cash_flow (annual, 2024-03-31) — Beginning Cash Position: 4373000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 28450000.00
HIVE.V cash_flow (annual, 2024-03-31) — Capital Expenditure: -78235000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 7638000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Capital Stock: 0.00
HIVE.V balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 9678000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 16652000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Cash Financial: 9678000.00
HIVE.V cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Financing Activities: 73004000.00
HIVE.V cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Investing Activities: -77341000.00
HIVE.V cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Operating Activities: 9640000.00
HIVE.V cash_flow (annual, 2024-03-31) — Change In Other Current Assets: 92602000.00
HIVE.V cash_flow (annual, 2024-03-31) — Change In Payables And Accrued Expense: -1191000.00
HIVE.V cash_flow (annual, 2024-03-31) — Change In Receivables: -772000.00
HIVE.V cash_flow (annual, 2024-03-31) — Change In Working Capital: -1963000.00
HIVE.V cash_flow (annual, 2024-03-31) — Changes In Cash: 5303000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Common Stock: 0.00
HIVE.V balance_sheet (annual, 2024-03-31) — Common Stock Equity: 259412000.00
HIVE.V cash_flow (annual, 2024-03-31) — Common Stock Issuance: 55701000.00
HIVE.V income_statement (annual, 2024-03-31) — Cost Of Revenue: 140542000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Current Accrued Expenses: 1878000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Current Assets: 185226000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 2304000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Current Debt: 10079000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 12383000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Current Liabilities: 27126000.00
HIVE.V cash_flow (annual, 2024-03-31) — Deferred Income Tax: 12962000.00
HIVE.V cash_flow (annual, 2024-03-31) — Deferred Tax: 12962000.00
HIVE.V cash_flow (annual, 2024-03-31) — Depreciation: 63599000.00
HIVE.V cash_flow (annual, 2024-03-31) — Depreciation Amortization Depletion: 63599000.00
HIVE.V cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 63599000.00
HIVE.V income_statement (annual, 2024-03-31) — Diluted Average Shares: 90005128.00
HIVE.V income_statement (annual, 2024-03-31) — Diluted EPS: 0.29
HIVE.V income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 26500000.00
HIVE.V income_statement (annual, 2024-03-31) — EBIT: 35709000.00
HIVE.V income_statement (annual, 2024-03-31) — EBITDA: 99308000.00
HIVE.V cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 2000.00
HIVE.V cash_flow (annual, 2024-03-31) — End Cash Position: 9678000.00
HIVE.V cash_flow (annual, 2024-03-31) — Financing Cash Flow: 73004000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Finished Goods: 161645000.00
HIVE.V cash_flow (annual, 2024-03-31) — Free Cash Flow: -68595000.00
HIVE.V cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -115149000.00
HIVE.V cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -1081000.00
HIVE.V income_statement (annual, 2024-03-31) — Gain On Sale Of Ppe: 82916000.00
HIVE.V income_statement (annual, 2024-03-31) — Gain On Sale Of Security: 6159000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Gains Losses Not Affecting Retained Earnings: 6329000.00
HIVE.V income_statement (annual, 2024-03-31) — General And Administrative Expense: 19155000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 0.00
HIVE.V balance_sheet (annual, 2024-03-31) — Gross PPE: 334657000.00
HIVE.V income_statement (annual, 2024-03-31) — Gross Profit: -26077000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Hedging Assets Current: 0.00
HIVE.V income_statement (annual, 2024-03-31) — Impairment Of Capital Assets: 0.00
HIVE.V cash_flow (annual, 2024-03-31) — Income Tax Paid Supplemental Data: 687000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Income Tax Payable: 4148000.00
HIVE.V income_statement (annual, 2024-03-31) — Interest Expense: 3024000.00
HIVE.V income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 3024000.00
HIVE.V cash_flow (annual, 2024-03-31) — Interest Paid Supplemental Data: 1555000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Inventory: 161645000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Invested Capital: 281886000.00
HIVE.V cash_flow (annual, 2024-03-31) — Investing Cash Flow: -77341000.00
HIVE.V cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 55701000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Land And Improvements: 749000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Line Of Credit: 5608000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 5334000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Long Term Debt: 12395000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 17729000.00
HIVE.V cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -4531000.00
HIVE.V cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: -647000.00
HIVE.V cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 55701000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Net Debt: 12796000.00
HIVE.V cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -20000.00
HIVE.V income_statement (annual, 2024-03-31) — Net Income: 26500000.00
HIVE.V income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 26500000.00
HIVE.V income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 26500000.00
HIVE.V income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 26500000.00
HIVE.V income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 26500000.00
HIVE.V cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 26500000.00
HIVE.V income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 26500000.00
HIVE.V income_statement (annual, 2024-03-31) — Net Interest Income: -3024000.00
HIVE.V cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -341000.00
HIVE.V cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -4531000.00
HIVE.V cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -4531000.00
HIVE.V income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -3024000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Net PPE: 102944000.00
HIVE.V cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -76353000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 259412000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Non Current Accounts Receivable: 2595000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Non Current Deferred Liabilities: 2415000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 2415000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 15917000.00
HIVE.V income_statement (annual, 2024-03-31) — Normalized EBITDA: 10233000.00
HIVE.V income_statement (annual, 2024-03-31) — Normalized Income: -45719290.19
HIVE.V cash_flow (annual, 2024-03-31) — Operating Cash Flow: 9640000.00
HIVE.V cash_flow (annual, 2024-03-31) — Operating Gains Losses: -19099000.00
HIVE.V income_statement (annual, 2024-03-31) — Operating Income: -53307000.00
HIVE.V income_statement (annual, 2024-03-31) — Operating Revenue: 114465000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 106080151.00
HIVE.V balance_sheet (annual, 2024-03-31) — Other Current Borrowings: 10079000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Other Equity Adjustments: 6329000.00
HIVE.V income_statement (annual, 2024-03-31) — Other Gand A: 8900000.00
HIVE.V income_statement (annual, 2024-03-31) — Other Income Expense: 89016000.00
HIVE.V cash_flow (annual, 2024-03-31) — Other Non Cash Items: -79608000.00
HIVE.V income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: -59000.00
HIVE.V income_statement (annual, 2024-03-31) — Other Operating Expenses: 6777000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Other Payable: 1251000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Other Properties: 305458000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 6974000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Payables: 12865000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Payables And Accrued Expenses: 14743000.00
HIVE.V income_statement (annual, 2024-03-31) — Pretax Income: 32685000.00
HIVE.V cash_flow (annual, 2024-03-31) — Proceeds From Stock Option Exercised: 21834000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Properties: 0.00
HIVE.V income_statement (annual, 2024-03-31) — Provision For Doubtful Accounts: 6777000.00
HIVE.V cash_flow (annual, 2024-03-31) — Purchase Of Business: -647000.00
HIVE.V cash_flow (annual, 2024-03-31) — Purchase Of Investment: -341000.00
HIVE.V cash_flow (annual, 2024-03-31) — Purchase Of PPE: -78235000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Receivables: 6929000.00
HIVE.V income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 140542000.00
HIVE.V income_statement (annual, 2024-03-31) — Reconciled Depreciation: 63599000.00
HIVE.V cash_flow (annual, 2024-03-31) — Repayment Of Debt: -4531000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Retained Earnings: -270866000.00
HIVE.V income_statement (annual, 2024-03-31) — Salaries And Wages: 10255000.00
HIVE.V cash_flow (annual, 2024-03-31) — Sale Of Investment: 0.00
HIVE.V cash_flow (annual, 2024-03-31) — Sale Of PPE: 1882000.00
HIVE.V income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 1298000.00
HIVE.V income_statement (annual, 2024-03-31) — Selling General And Administration: 20453000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Share Issued: 106080151.00
HIVE.V income_statement (annual, 2024-03-31) — Special Income Charges: 82916000.00
HIVE.V cash_flow (annual, 2024-03-31) — Stock Based Compensation: 7249000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Stockholders Equity: 259412000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Tangible Book Value: 259412000.00
HIVE.V income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 16855709.81
HIVE.V income_statement (annual, 2024-03-31) — Tax Provision: 6185000.00
HIVE.V income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.19
HIVE.V balance_sheet (annual, 2024-03-31) — Total Assets: 306682000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Total Capitalization: 271807000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Total Debt: 30112000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 259412000.00
HIVE.V income_statement (annual, 2024-03-31) — Total Expenses: 167772000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 47270000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 121456000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 20144000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Total Tax Payable: 4148000.00
HIVE.V income_statement (annual, 2024-03-31) — Total Unusual Items: 89075000.00
HIVE.V income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 89075000.00
HIVE.V cash_flow (annual, 2024-03-31) — Unrealized Gain Loss On Investment Securities: -3743000.00
HIVE.V balance_sheet (annual, 2024-03-31) — Working Capital: 158100000.00
HIVE.V income_statement (annual, 2024-03-31) — Write Off: 0.00
HIVE.V income_statement (quarterly, 2024-09-30) — Basic Average Shares: 118593637.00
HIVE.V income_statement (quarterly, 2024-09-30) — Basic EPS: 0.00
HIVE.V cash_flow (quarterly, 2024-09-30) — Change In Other Current Assets: 14346000.00
HIVE.V income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 118593637.00
HIVE.V income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.00
HIVE.V balance_sheet (quarterly, 2024-09-30) — Line Of Credit: 4631000.00
HIVE.V balance_sheet (quarterly, 2024-09-30) — Net Debt: 12892000.00
HIVE.V cash_flow (quarterly, 2024-09-30) — Purchase Of Investment: -558000.00
HIVE.V cash_flow (quarterly, 2024-09-30) — Unrealized Gain Loss On Investment Securities: -8383000.00
HIVE.V income_statement (quarterly, 2024-12-31) — +Operating Expense: 8090000.00
HIVE.V income_statement (quarterly, 2024-12-31) — +Total Revenue: 29229000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 7983000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 8910000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -232814000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Basic Average Shares: 128602843.00
HIVE.V income_statement (quarterly, 2024-12-31) — Basic EPS: 0.53
HIVE.V cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 7241000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 31573000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -62224000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 6537000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Capital Stock: 620900000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 9845000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 40545000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Cash Financial: 9845000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: 84594000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: -53364000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: -28464000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Change In Other Current Assets: 7802000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: -8340000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Change In Receivables: -2362000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Change In Working Capital: -10702000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Changes In Cash: 2766000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Common Stock: 620900000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 434360000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 85098000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 42002000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 2602000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Current Assets: 310261000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 2701000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Current Debt: 9671000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 12372000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 29806000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Deferred Income Tax: 123000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Deferred Tax: 123000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Depreciation: 18050000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 18050000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 18050000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 131525323.00
HIVE.V income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.52
HIVE.V income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 68160000.00
HIVE.V income_statement (quarterly, 2024-12-31) — EBIT: 68702000.00
HIVE.V income_statement (quarterly, 2024-12-31) — EBITDA: 86752000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Effect Of Exchange Rate Changes: -162000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — End Cash Position: 9845000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: 84594000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Finished Goods: 260806000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Free Cash Flow: -90688000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: -26865000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: -6924000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Gain On Sale Of Ppe: 6924000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 82519000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 164469000.00
HIVE.V income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 7571000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Gross PPE: 348504000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Gross Profit: -12773000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 0.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Income Tax Payable: 5568000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Interest Expense: 419000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 419000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Interest Paid Supplemental Data: 0.00